A Case Series Study to Assess the Clinical and Socio Demographic Aspects of MDR TB Clients Admitted in Selected Hospitals of Indore

The World Health Organization (WHO) defines multidrug-resistant tuberculosis (MDR-TB) as resistance to isoniazid and rifampicin, with or without resistance to other anti-tuberculosis drugs. MDR-TB is a subtype of multidrug-resistant tuberculosis (MDR-TB). It is becoming a significant concern for human health on a global basis, and it presents a threat to the efforts being made to control tuberculosis. According to the most recent statistics on the monitoring of anti-TB drug resistance, it is estimated that 4.3% of newly diagnosed cases and 18% of previously treated cases of tuberculosis across the globe have rifampicin- or multidrug-resistant tuberculosis. This percentage applies to cases that have been diagnosed with tuberculosis for the first time (MDR- or RR-TB). According to estimates, there were around 700,000 newly diagnosed cases of MDR/RR-TB reported throughout the globe in 2018. In India, it is anticipated that each year there will be 1.4 lakh newly diagnosed cases of MDR-TB, with 80,000 of those cases being MDR-TB. In the United States, the number of newly diagnosed cases of MDR-TB is estimated to reach 90,000.In light of the fact that the chest X-ray (CXR) symptoms of pulmonary tuberculosis are dependent on a variety of characteristics, such as age and immunological status, identifying the influence of HIV on the CXR appearances of MDR-TB may be of some help. Multidrug-resistant tuberculosis (also known as MDR-TB) is a condition that is becoming an increasingly significant problem as a result of inadequate treatment of drug-sensitive as well as drug-resistant tuberculosis. Both multidrug-resistant tuberculosis and regular tuberculosis may be cured; however, treatment can be prohibitively expensive, take a very long time, and require treatments that might be potentially hazardous. There have only been a few studies done that look at the clinical and demographic features of MDR-TB. Investigating the socio demographic aspects of multidrug-resistant pulmonary tuberculosis is the goal of this study